Advanced search
Log in
Forgot password ?
Remember
Or log in with
Google
Twitter
Facebook
Apple
Sign up
Email Registration
Or log in with
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
Markets
Equities
Top Capitalization
United States
North America
Europe
Asia
Middle East
Sector Research
Financial Calendar
Equities Analysis
Most popular
ALPHABET INC.
MICROSOFT CORPORATION
META PLATFORMS, INC.
APPLE INC.
AMAZON.COM, INC.
TESLA, INC.
NVIDIA CORPORATION
Indexes
Homepage
Rankings
Europe
America
Asia
Africa
Index Analysis
Indexes News
S&P 500
DOW JONES
NASDAQ 100
TSX COMP
FTSE 100
DAX
CAC 40
EURO STOXX 50
Currency / Forex
Homepage
Rankings
Currency Cross Rate
Currency Converter
Forex Analysis
Currencies News
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
Commodities
Homepage
Energy
Precious metals
Agriculture
Industrial Metals
Livestock and Cattle
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
Cryptocurrencies
Homepage
Rankings
Charts
Analysis
News
BITCOIN
ETHEREUM
BINANCE COIN
SOLANA
CARDANO
FTX TOKEN
Interest Rates
Homepage
Developed Nations
Emerging Countries
ETFs Rates
ETF
Rankings and News
Advanced Search
News
All News
World
United States
Europe
North America
South America
Asia
Africa
Middle East
Emerging
Companies
All News
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Security Transactions
Earnings reports
New markets
New products
Corporate strategies
Legal risks
Share buybacks
Mergers and acquisitions
Call Transcripts
Guidance
Indexes
Currency / Forex
Commodities
Cryptocurrencies
ETF
Interest Rates
Economy
Themes
Asset Management
Activism
Climate and ESG
Cybersecurity
Geopolitics
Central Banks
Private Equity
Inflation
Business Leaders
Sectors
All our articles
Most Read News
Hot News
Analysis
All Analysis
Must Read
Equities
Indexes
Currencies
Commodities
Cryptocurrencies
Stock Trading Strategies
All
America
Europe
Asia
Our Shows
Shows
World Press Review
Pump & Dump
Must Watch
Satirical Cartoon
Today's Editorial
Crypto Recap
Stock Picks
Portfolios
Virtual Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Watchlists
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Homepage
Trend-Following Stocks
Momentum stocks
Undervalued stocks
Quality stocks
Yield stocks
ESG stocks
Investment Themes
Homepage
Sin stocks
Education
Robotics
The Golden Age of Video Games
In Vino Veritas
Boats
Rankings
Top Movers
Top Movers
Unusual volumes
New Historical Highs
New Historical Lows
Long Term
Top Fundamentals
Top Fundamentals
Sales growth
Earnings Growth
Profitability
Finances
Rankings Valuation
Rankings Valuation
P/E ratio
Enterprise value
Yield
Top Consensus
Top Consensus
Analyst Opinion
Target price
Estimates Revisions
Divergence
Top Technicals
Top RSI
Unusual volumes
GAPS
STIM
Breakouts
Trends
Volatility
Top ranking ESG
Top ranking ESG
Environnement
Social
Gouvernance
Rankings Coverage
Screeners
Stock Screener Home
Investment Themes
The Cannabis Industry
Robotics
Financial Data
The Golden Age of Video Games
In Vino Veritas
Cybersecurity
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Low valuations
My Screeners
All my stocks
Watchlists
Virtual Portfolios
Tools
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Dynamic Chart
Financial Calendar
Economic Calendar
Currency Converter
ProRealTime Trading
Our Services
Our subscriptions
Our Stock Picks
Stock Screener
Thematic Investment Lists
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Homepage
Equities
United States
Nyse
Bristol-Myers Squibb Company
News
Summary
BMY
US1101221083
BRISTOL-MYERS SQUIBB COMPANY
(BMY)
Add to my list
Report
Delayed Nyse -
04:00:01 2023-02-06 pm EST
74.53
USD
+0.11%
04:22p
Bristol-Myers Squibb to Return Development Rights for IL -12 Investigational Immunotherapy Program to Dragonfly
MT
09:51a
Bristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Conference
AQ
02/03
Morgan Stanley Adjusts Price Target on Bristol-Myers Squibb to $62 From $60, Maintains Underweight Rating
MT
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Funds
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
MarketScreener Strategies
Most relevant news about BRISTOL-MYERS SQUIBB COMPANY
04:22p
Bristol-Myers Squibb to Return Development Rights for IL -12 Investigational Immunother..
MT
09:51a
Bristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Co..
AQ
02/03
Morgan Stanley Adjusts Price Target on Bristol-Myers Squibb to $62 From $60, Maintains ..
MT
02/03
Atlantic Equities Adjusts Bristol-Myers Squibb's Price Target to $90 From $88, Maintain..
MT
02/03
Bristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Co..
BU
02/02
Trending: Bristol Myers Squibb Beats 4Q Sales Expectations
DJ
02/02
Transcript : Bristol-Myers Squibb Company, Q4 2022 Earnings Call, Feb 02, 202..
CI
02/02
Bristol Myers Squibb : Q4 2022 Results Presentation
PU
02/02
Bristol Myers Squibb : Q4 2022 Results Presentation (with Appendix)
PU
02/02
Tranche Update on Bristol-Myers Squibb Company's Equity Buyback Plan announced on Octob..
CI
02/02
Bristol-Myers Squibb Q4 Non-GAAP Earnings, Revenue Decline; Provides 2023 Guidance
MT
02/02
Earnings Flash (BMY) BRISTOL MYERS SQUIBB Posts Q4 Revenue $11.41B, vs. Street Est of $..
MT
02/02
Earnings Flash (BMY) BRISTOL MYERS SQUIBB Posts Q4 EPS $1.82, vs. Street Est of $1.73
MT
02/02
Bristol Myers : Q4 Earnings Snapshot
AQ
02/02
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2022
BU
More most relevant news
All news about BRISTOL-MYERS SQUIBB COMPANY
04:22p
Bristol-Myers Squibb to Return Development Rights for IL -12 Investigational Immunother..
MT
09:51a
Bristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Co..
AQ
02/03
Morgan Stanley Adjusts Price Target on Bristol-Myers Squibb to $62 From $60, Maintains ..
MT
02/03
Atlantic Equities Adjusts Bristol-Myers Squibb's Price Target to $90 From $88, Maintain..
MT
02/03
Bristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Co..
BU
02/02
Exscientia Says EXS4318 Drug Candidate Has Entered Phase 1 Clinical Trials in US -- Sha..
MT
02/02
Trending: Bristol Myers Squibb Beats 4Q Sales Expectations
DJ
02/02
Transcript : Bristol-Myers Squibb Company, Q4 2022 Earnings Call, Feb 02, 202..
CI
02/02
Bristol Myers Squibb : Q4 2022 Results Presentation
PU
02/02
Bristol Myers Squibb : Q4 2022 Results Presentation (with Appendix)
PU
More news
News in other languages on BRISTOL-MYERS SQUIBB COMPANY
04:22p
Bristol-Myers Squibb rendra à Dragonfly les droits de développement du programme d'immu..
02/02
Exscientia déclare que le médicament candidat EXS4318 est entré en phase 1 des essais c..
02/02
Bristol-Myers : BPA quasi-stable au 4e trimestre
02/02
Baisse du bénéfice non GAAP et du chiffre d'affaires de Bristol-Myers Squibb au 4e trim..
02/02
Bristol-Myers Squibb Company fournit des prévisions de résultats pour l'année 2023
02/02
Les actions restent généralement fermes avant la cloche, stimulées par les perspectives..
02/02
Les perspectives de désinflation et les plateformes méta font grimper les contrats à te..
02/02
Marketmind : Fed fillip, double trouble, triple A
01/31
Prothena obtient des résultats " positifs " de l'étude de phase 1 sur le traitement à d..
01/31
Bristol-Myers Squibb Company annonce la démission du Dr Rupert Vessey, vice-président e..
More news
Analyst Recommendations on BRISTOL-MYERS SQUIBB COMPANY
02/03
Morgan Stanley Adjusts Price Target on Bristol-Myers Squibb to $62 From $60, Maintains ..
MT
02/03
Atlantic Equities Adjusts Bristol-Myers Squibb's Price Target to $90 From $88, Maintain..
MT
01/31
UBS Adjusts Bristol-Myers Squibb Price Target to $77 From $75, Maintains Neutral Rating
MT
01/17
Cantor Fitzgerald Starts Bristol-Myers Squibb at Overweight With $95 Price Target
MT
01/03
Wells Fargo Ups Price Target on Bristol-Myers Squibb to $78 From $70, Reiterates Equalw..
MT
More recommendations
Press releases
09:51a
Bristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Co..
AQ
02/03
Bristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Co..
BU
02/02
Bristol Myers Squibb : Q4 2022 Results Presentation
PU
02/02
Bristol Myers Squibb : Q4 2022 Results Presentation (with Appendix)
PU
02/02
Bristol Myers Squibb Co : Results of Operations and Financial Condition, Regulation FD Dis..
AQ
More press releases
Powered by Scoopnest.com
Analysis
Pharmaceutical companies still have the upper hand
More Must read
Upcoming event on BRISTOL-MYERS SQUIBB COMPANY
02/09/23
Guggenheim Healthcare Talks Oncology Conference
Company calendar
Upcoming sector events
04/18/23
JOHNSON & JOHNSON : Q1 2023 Earnings Release
04/27/23
ELI LILLY AND COMPANY : Q1 2023 Earnings Release
04/27/23
MERCK & CO., INC. : Q1 2023 Earnings Release
05/04/23
NOVO NORDISK A/S : Q1 2023 Earnings Release
More events
Sector
Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals
Slave